Large-scale testing (Phase 3)Study completedNCT04917523
What this trial is testing
Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above
Who this might be right for
COVID-19 PneumoniaCOVID-19
China National Biotec Group Company Limited 1,800